Literature DB >> 17680229

Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases.

R A Armstrong1, P L Lantos, N J Cairns.   

Abstract

In eight cases of progressive supranuclear palsy (PSP), neurofibrillary tangles (NFT) were numerous in the substantia nigra (SN), red nucleus (RN), locus caeruleus (LC), pontine nuclei (PN), and inferior olivary nucleus (ION) and abnormally enlarged neurons (EN) in the ION, LC and PN. Loss of Purkinje cells was evident in the cerebellum. Tufted astrocytes (TA) were abundant in the striatum, SN and RN and glial inclusions ('coiled bodies') (GI) in the midbrain (SN, RN) and pons (LC). Neuritic plaques were frequent in one case. NFT, GI, and TA densities were uncorrelated in most areas. NFT and EN densities were positively correlated in the midbrain and surviving neurons and disease duration in several areas. These results suggest: 1) predominantly subcortical pathology in PSP with widespread NFT while TA and GI have a more localized distribution, 2) little correlation between neuronal and glial pathologies, and 3) shorter duration cases may be more likely to develop cortical pathology.

Entities:  

Mesh:

Year:  2007        PMID: 17680229     DOI: 10.1007/s00702-007-0796-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  43 in total

1.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

2.  Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.

Authors:  C Bergeron; M S Pollanen; L Weyer; A E Lang
Journal:  J Neuropathol Exp Neurol       Date:  1997-06       Impact factor: 3.685

3.  Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome.

Authors:  I Tellez-Nagel; H M Wiśniewski
Journal:  Arch Neurol       Date:  1973-11

Review 4.  [Cortical lesions in progressive supranuclear palsy (Steele-Richardson-Olszewski disease)].

Authors:  M Verny; C Duyckaerts; J J Hauw
Journal:  Rev Neurol (Paris)       Date:  1999-01       Impact factor: 2.607

5.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

Authors:  K A Josephs; B F Boeve; J R Duffy; G E Smith; D S Knopman; J E Parisi; R C Petersen; D W Dickson
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

6.  Clinical genetics of familial progressive supranuclear palsy.

Authors:  A Rojo; R S Pernaute; A Fontán; P G Ruíz; J Honnorat; T Lynch; S Chin; I Gonzalo; A Rábano; A Martínez; S Daniel; P Pramstaller; H Morris; N Wood; A Lees; C Tabernero; T Nyggard; A C Jackson; A Hanson; J G de Yébenes; P Pramsteller
Journal:  Brain       Date:  1999-07       Impact factor: 13.501

7.  Quantification of pathological lesions in the frontal and temporal lobe of ten patients diagnosed with Pick's disease.

Authors:  R A Armstrong; N J Cairns; P L Lantos
Journal:  Acta Neuropathol       Date:  1999-05       Impact factor: 17.088

8.  Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.

Authors:  Takashi Togo; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2002-05-30       Impact factor: 17.088

9.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue.

Authors:  T Yamada; P L McGeer; E G McGeer
Journal:  Neurosci Lett       Date:  1992-01-20       Impact factor: 3.046

10.  Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.

Authors:  P R Hof; A Delacourte; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more
  10 in total

1.  Clustering of tau-immunoreactive pathology in chronic traumatic encephalopathy.

Authors:  Richard A Armstrong; Ann C McKee; Victor E Alvarez; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2016-10-21       Impact factor: 3.575

2.  Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.

Authors:  Brinda Desai Bradaric; Aditiben Patel; Julie A Schneider; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2011-07-12       Impact factor: 3.575

3.  Spatial patterns of the tau pathology in progressive supranuclear palsy.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  Neurol Sci       Date:  2012-03-13       Impact factor: 3.307

4.  Free-water imaging in Parkinson's disease and atypical parkinsonism.

Authors:  Peggy J Planetta; Edward Ofori; Ofer Pasternak; Roxana G Burciu; Priyank Shukla; Jesse C DeSimone; Michael S Okun; Nikolaus R McFarland; David E Vaillancourt
Journal:  Brain       Date:  2015-12-24       Impact factor: 13.501

5.  PET imaging of neuropathology in tauopathies: progressive supranuclear palsy.

Authors:  Vladimir Kepe; Yvette Bordelon; Adam Boxer; Sung-Cheng Huang; Jie Liu; Frederick C Thiede; John C Mazziotta; Mario F Mendez; Natacha Donoghue; Gary W Small; Jorge R Barrio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.

Authors:  Hye-Jin Park; Kang-Woo Lee; Stephanie Oh; Run Yan; Jie Zhang; Thomas G Beach; Charles H Adler; Michael Voronkov; Steven P Braithwaite; Jeffry B Stock; M Maral Mouradian
Journal:  J Neuropathol Exp Neurol       Date:  2018-02-01       Impact factor: 3.685

7.  Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis.

Authors:  Maj-Linda B Selenica; Hayk Davtyan; Steven B Housley; Laura J Blair; Anne Gillies; Bryce A Nordhues; Bo Zhang; Joseph Liu; Jason E Gestwicki; Daniel C Lee; Marcia N Gordon; Dave Morgan; Chad A Dickey
Journal:  J Neuroinflammation       Date:  2014-09-03       Impact factor: 8.322

8.  How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.

Authors:  Momoko Ebashi; Yoshinori Ito; Miho Uematsu; Ayako Nakamura; Katsuiku Hirokawa; Satoshi Kamei; Toshiki Uchihara
Journal:  Acta Neuropathol Commun       Date:  2019-05-06       Impact factor: 7.801

9.  Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.

Authors:  Annette Janzen; Douglas P Munoz; Mahboubeh Habibi; Wolfgang H Oertel; Brian J White; Donald C Brien; Brian C Coe; Heidi C Riek; Julia Perkins; Rachel Yep; Laurent Itti; Lars Timmermann; Christoph Best; Elisabeth Sittig
Journal:  J Neurol       Date:  2022-04-30       Impact factor: 6.682

10.  Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.

Authors:  Tomoko Miki; Osamu Yokota; Takashi Haraguchi; Hideki Ishizu; Masato Hasegawa; Takeshi Ishihara; Shu-Ichi Ueno; Shintaro Takenoshita; Seishi Terada; Norihito Yamada
Journal:  Brain Pathol       Date:  2020-05-06       Impact factor: 6.508

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.